Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 2 minute read Pharma Industry News Iksuda Therapeutics advances IKS014 in Phase 1 trial following positive initial results Iksuda Therapeutics, a clinical-stage biotechnology firm from the UK specializing in innovative antibody drug conjugates (ADCs) for tumor… byPallavi MadhirajuOctober 24, 2023